Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Senti Biosciences Holdings, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −1 vs. Q3 2025
- Shares held
- 5.61M
- −248.8K (−4.2%) vs. Q3 2025
- Total value
- $5.84M
- −$2.43M (−29.4%) vs. Q3 2025
- New holders
- 4
- 4 more added
- Sold out
- 5
- 2 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $6.37M |
| Q1 2026 | 16 | $4.58M |
| Q4 2025 | 15 | $5.84M |
| Q3 2025 | 16 | $8.27M |
| Q2 2025 | 15 | $14.2M |
| Q1 2025 | 16 | $19.9M |
| Q4 2024 | 16 | $3.23M |
| Q3 2024 | 14 | $2.41M |
| Q2 2024 | 20 | $2.17M |
| Q1 2024 | 27 | $4.15M |
| Q4 2023 | 25 | $7.56M |
| Q3 2023 | 26 | $5.02M |
| Q2 2023 | 28 | $7.64M |
| Q1 2023 | 24 | $14.3M |
| Q4 2022 | 26 | $16.6M |
| Q3 2022 | 23 | $27.8M |
| Q2 2022 | 20 | $22.1M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Senti Biosciences Holdings, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 75 | $78 | 0.00% | −375−83.3% | Reduced |
| Morgan Stanley | 160 | $166 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 336 | $349 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,411 | $3.55K | 0.00% | +1,681+97.2% | Added |
| UBS Group AG | 4,529 | $4.71K | 0.00% | +4,529 | New |
| State Street Corp | 10,010 | $10.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,778 | $17.4K | 0.00% | +468+2.9% | Added |
| BlackRock, Inc. | 23,384 | $24.3K | 0.00% | +780+3.5% | Added |
| Msop GP, L.L.C. | 35,737 | $37.2K | 0.01% | +35,737 | New |
| Jane Street Group, LLC | 38,427 | $40.0K | 0.00% | +38,427 | New |
| Virtu Financial LLC | 44,409 | $46.0K | 0.00% | +44,409 | New |
| Geode Capital Management, LLC | 144,797 | $150.6K | 0.00% | −8,041−5.3% | Reduced |
| Vanguard Group Inc | 628,697 | $653.8K | 0.00% | +12,624+2.0% | Added |
| Nantahala Capital Management, LLC | 888,000 | $923.5K | 0.06% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,775,615 | $3.93M | 0.20% | 00.0% | Unchanged |
| 8VC GP I, LLC | 0 | $0 | 0.00% | −253,755−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −82,753−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −26,567−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −15,968−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |